Table 3.
Association studies of bronchial and emphysematous COPD types with annual FEV1 decline (ΔFEV1), cigarette smoking, body mass index (BMI) and SERPINA1 genotypes.
| Type/Class | COPD phenotype
|
p | |
| CB | CLE+PEL | ||
| ΔFEV1 (ml/year) | 171 ± 137 | 232 ± 239 | 0.243a |
| Cumulative cigarette consumption | 59.41 ± 29.22 | 51.97 ± 28.68 | 0.230a |
| BMI (kg/m2) | 24.33 ± 3.70 | 22.77 ± 5.21 | 0.117a |
| M1Ala | 0.41 | 0.53 | |
| No M1Ala | 0.58 | 0.47 | 0.306b |
| M2 | 0.45 | 0.45 | |
| No M2 | 0.54 | 0.54 | 1b |
| M3 | 0.39 | 0.53 | |
| No M3 | 0.60 | 0.46 | 0.184b |
CB: Chronic Bronchitis; CLE: Centrolobular Emphysema; PLE: Panlobular Emphysema; Cumulative cigarette consumption = number of packs smoked per day multiplied by years of consumption. M1Ala: heterozygous and homozygous for Ala213 allele; no M1Ala: homozygous for Val213 allele; M2: heterozygous and homozygous for His101allele; no M2: homozygous for Arg101 allele; M3: heterozygous and homozygous for Asp376 allele; no M3: homozygous for Glu376 allele.
aStudent's t test; bPearson's χ2 test.